Gallagher’s resignation may slow Biosecure Act

The decision by Rep. Mike Gallagher (R-Wis.) to resign next month will take some of the steam out of the Biosecure Act, but congressional concerns that Chinese biotechnology companies pose national security threats isn’t dissipating. 

The departure of Gallagher, chairman of the House Select Committee on the Chinese Communist Party, could slow the legislation’s progress, providing opportunities to modify it to reduce negative impacts on drug developers. The absence of the bill’s strongest proponent increases chances that provisions that would be most disruptive to drug developers, bans on Chinese contract development and manufacturing organizations (CDMOs), will be stripped away or watered-down. ...